InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

Current share price for MAP : $0.048 0.001 (2.04%)+

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$34 Change of Director's Interest Notice - Pasquale Rombola 31 Jul 2026 3:05PM $0.048 $0.048 fallen by 0%
$34 Change of Director's Interest Notice - Prof Ian Frazer 31 Jul 2026 3:03PM $0.048 $0.048 fallen by 0%
$34 Cleansing Notice 29 Jul 2026 5:20PM $0.047 $0.048 risen by 2.13%
$34 Notification regarding unquoted securities - MAP 29 Jul 2026 10:38AM $0.048 $0.048 fallen by 0%
$34 Notification regarding unquoted securities - MAP 29 Jul 2026 10:38AM $0.048 $0.048 fallen by 0%
$34 Application for quotation of securities - MAP 29 Jul 2026 10:38AM $0.048 $0.048 fallen by 0%
$34 Notification regarding unquoted securities - MAP 29 Jul 2026 10:38AM $0.048 $0.048 fallen by 0%
$34 Application for quotation of securities - MAP 29 Jul 2026 10:27AM $0.048 $0.048 fallen by 0%
$34 Completion of Share Purchase Plan 28 Jul 2026 9:39AM $0.046 $0.048 risen by 4.35%
$34 Results of General Meeting 24 Jul 2026 5:29PM $0.045 $0.048 risen by 6.67%
$34 Microba signs multi-year SYNLAB agreement 20 Jul 2026 9:04AM $0.044 $0.048 risen by 9.09%
$34 Q4 FY26 Quarterly Investor Presentation & Webinar 16 Jul 2026 9:12AM $0.041 $0.048 risen by 17.07%
$34 Q4 FY26 Quarterly Activities Report & Appendix 4C 16 Jul 2026 9:03AM $0.041 $0.048 risen by 17.07%
$34 Change in substantial holding 14 Jul 2026 4:36PM $0.041 $0.048 risen by 17.07%
$34 Details of Q4 FY26 Quarterly Report, Appendix 4C & Webinar 14 Jul 2026 12:09PM $0.041 $0.048 risen by 17.07%
$34 Ceasing to be a substantial holder 23 Jun 2026 4:07PM $0.039 $0.048 risen by 23.08%
$34 Letter to Shareholders, Notice of EGM & Proxy Form 23 Jun 2026 4:04PM $0.039 $0.048 risen by 23.08%
$34 Change in substantial holding 19 Jun 2026 5:01PM $0.037 $0.048 risen by 29.73%
$34 Cleansing Notice 19 Jun 2026 9:14AM $0.037 $0.048 risen by 29.73%
$34 Letter to SPP Eligible Shareholders 19 Jun 2026 9:12AM $0.037 $0.048 risen by 29.73%
$34 Disclosure Document - Prospectus 19 Jun 2026 9:09AM $0.037 $0.048 risen by 29.73%
$34 Application for quotation of securities - MAP 18 Jun 2026 10:08AM $0.038 $0.048 risen by 26.32%
$34 Reinstatement to Quotation 12 Jun 2026 9:46AM $0.063 $0.048 fallen by 23.81%
$34 Proposed issue of securities - MAP 12 Jun 2026 9:46AM $0.063 $0.048 fallen by 23.81%
$34 Proposed issue of securities - MAP 12 Jun 2026 9:46AM $0.063 $0.048 fallen by 23.81%

1 - 25 of 693 results

Page 1 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.